Research graph
References from Clinically Meaningful Change for Physical Performance: Perspectives of the ICFSR Task Force. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2001 · External reference
Toward a common language for function, disability, and health
10.1093/ptj/86.5.726 · 2006 · External reference
Clinical trials on sarcopenia: methodological issues regarding phase 3 trials
10.1016/j.cger.2011.03.010 · 2011 · External reference
Sarcopenia Trials in Specific Diseases: Report by the International Conference on Frailty and Sarcopenia Research Task Force
2016 · External reference
Designing pharmaceutical trials for sarcopenia in frail older adults: EU/US Task Force recommendations
10.1007/s12603-013-0362-7 · 2013 · External reference
Muscle Quality, Strength, and Lower Extremity Physical Performance in the Baltimore Longitudinal Study of Aging
2017 · External reference
Sarcopenia: clinical evaluation, biological markers and other evaluation tools
10.1007/s12603-009-0204-9 · 2009 · External reference
Meaningful change and responsiveness in common physical performance measures in older adults
10.1111/j.1532-5415.2006.00701.x · 2006 · External reference
A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission
10.1093/geronj/49.2.m85 · 1994 · External reference
The Timed “Up & Go”: A test of basic functional mobility for frail elderly persons
10.1111/j.1532-5415.1991.tb01616.x · 1991 · External reference
Pharmacological Interventions in Frailty and Sarcopenia: Report by the International Conference on Frailty and Sarcopenia Research Task Force
2015 · External reference
Meaningful change in measures of gait variability in older adults
10.1016/j.gaitpost.2009.10.002 · 2010 · External reference
Clinically meaningful change in stair negotiation performance in older adults
10.1016/j.gaitpost.2012.05.015 · 2012 · External reference
Magnitude and patterns of decline in health and function in 1 year affect subsequent 5-year survival
10.1093/gerona/60.7.894 · 2005 · External reference
Beyond statistical significance: clinical interpretation of rehabilitation research literature
2014 · External reference
Individual-patient monitoring in clinical practice: are available health status surveys adequate?
10.1007/bf01593882 · 1995 · External reference
Are estimates of meaningful decline in mobility performance consistent among clinically important subgroups? (Health ABC study)
10.1093/gerona/glu033 · 2014 · External reference
What is a meaningful change in physical performance? Findings from a clinical trial in older adults (the LIFE-P study)
10.1007/s12603-009-0104-z · 2009 · External reference
Quality criteria were proposed for measurement properties of health status questionnaires
10.1016/j.jclinepi.2006.03.012 · 2007 · External reference
Just get out the door! Importance of walking outside the home for maintaining mobility: findings from the women's health and aging study
10.1111/j.1532-5415.2005.53103.x · 2005 · External reference
What are the outcomes of treatment among patients with sarcopenia?
10.1007/s12603-009-0206-7 · 2009 · External reference
Functional ability perceived by individuals following total knee arthroplasty compared to age-matched individuals without knee disability
10.2519/jospt.1998.27.4.255 · 1998 · External reference
Assessment of physical functioning in recurrent glioma: preliminary comparison of performance status to functional capacity testing
10.1007/s11060-009-9803-x · 2009 · External reference
The relationship between self-report and performance-related measures: questioning the content validity of timed tests
10.1002/art.11196 · 2003 · External reference
Performance measures provide assessments of pain and function in people with advanced osteoarthritis of the hip or knee
10.2522/ptj.20060002 · 2006 · External reference
Adverse events associated with testosterone administration
10.1056/nejmoa1000485 · 2010 · External reference
Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People
10.1093/ageing/afq034 · 2010 · External reference
The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates
10.1093/gerona/glu010 · 2014 · External reference
Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial
10.1001/jama.2016.11136 · 2016 · External reference
Unresolved reference
External reference
Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement
10.1016/j.joca.2015.07.001 · 2015 · External reference
Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT)
10.1136/annrheumdis-2016-210860 · 2017 · External reference
Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQoL
10.1093/ageing/afv133 · 2015 · External reference
FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab
10.1002/jbmr.3427 · 2018 · External reference
Measuring Sarcopenia Severity in Older Adults and the Value of Effective Interventions
10.1007/s12603-018-1104-7 · 2018 · External reference
Management of Patients With High Baseline Hip Fracture Risk by FRAX Reduces Hip Fractures-A Post Hoc Analysis of the SCOOP Study
10.1002/jbmr.3411 · 2018 · External reference
